Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Compound Ferrous Sulfate Folic Acid Tablets	111.88M
Compound Ferrous Sulfate Folic Acid Tablets Growth	-3.60%
Risperidone Oral Disintegration Tablets	104.15M
Risperidone Oral Disintegration Tablets Growth	38.93%
Escitalopram Oxalate Tablets	15.14M
Escitalopram Oxalate Tablets Growth	0.97%
Ferrous Fumarate API	8.23M
Ferrous Fumarate API Growth	5.42%
Daphne Capsules	7.42M
Daphne Capsules Growth	9.66%
Ferrous Sulfate API	4.55M
Ferrous Sulfate API Growth	55.56%
Sodium Ferulate API	2.15M
Sodium Ferulate API Growth	68.42%
Zinc Sulfate	1.65M
Other Business	1.16M
Other Business Growth	230.89%
Other	80.72K
Other Growth	173.08%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	256.41M
China Growth	13.71%